ECSP14019113A - Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina - Google Patents

Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Info

Publication number
ECSP14019113A
ECSP14019113A ECIEPI201419113A ECPI201419113A ECSP14019113A EC SP14019113 A ECSP14019113 A EC SP14019113A EC IEPI201419113 A ECIEPI201419113 A EC IEPI201419113A EC PI201419113 A ECPI201419113 A EC PI201419113A EC SP14019113 A ECSP14019113 A EC SP14019113A
Authority
EC
Ecuador
Prior art keywords
chemical entities
activating enzyme
ubiquitin activating
pyrazolopyrimidinyl
inhibitors
Prior art date
Application number
ECIEPI201419113A
Other languages
English (en)
Spanish (es)
Inventor
Roushan Afroze
Francois Soucy
Indu Bharathan
Jeffrey Ciavarri
Tzu-Tshin Wong
Paul Fleming
Mario Girard
Yingchun Ye
Jeffrey Gaulin
Steven Langston
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of ECSP14019113A publication Critical patent/ECSP14019113A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ECIEPI201419113A 2012-02-17 2014-09-17 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina ECSP14019113A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17

Publications (1)

Publication Number Publication Date
ECSP14019113A true ECSP14019113A (es) 2015-09-30

Family

ID=48982730

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201419113A ECSP14019113A (es) 2012-02-17 2014-09-17 Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina

Country Status (30)

Country Link
US (4) US9290500B2 (https=)
EP (3) EP2814791A4 (https=)
JP (1) JP6122877B2 (https=)
KR (1) KR20140123104A (https=)
CN (1) CN104136399B (https=)
AR (1) AR092797A1 (https=)
BR (1) BR112014020365B1 (https=)
CA (1) CA2864672C (https=)
CL (1) CL2014002181A1 (https=)
CO (1) CO7071135A2 (https=)
CR (1) CR20140380A (https=)
DO (1) DOP2014000187A (https=)
EA (1) EA035020B1 (https=)
EC (1) ECSP14019113A (https=)
ES (1) ES2739150T3 (https=)
GE (1) GEP201706687B (https=)
HK (1) HK1201817A1 (https=)
IL (1) IL234016A0 (https=)
MA (1) MA35932B1 (https=)
MX (1) MX352963B (https=)
NZ (1) NZ628969A (https=)
PE (1) PE20142244A1 (https=)
PH (1) PH12014501832A1 (https=)
SG (2) SG10201606581RA (https=)
TN (1) TN2014000351A1 (https=)
TW (1) TWI593688B (https=)
UA (1) UA116534C2 (https=)
UY (1) UY34629A (https=)
WO (1) WO2013123169A1 (https=)
ZA (1) ZA201406103B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JP6697453B2 (ja) * 2014-10-29 2020-05-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. ユビキチン活性化酵素阻害物質及び放射線の投与
WO2016069392A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
AU2019370200B2 (en) 2018-10-30 2024-12-19 Kronos Bio, Inc. Compounds, compositions, and methods for modulating CDK9 activity
WO2022253188A1 (en) * 2021-05-31 2022-12-08 Impact Therapeutics (Shanghai) , Inc Nitrogen-containing fused heteroaromatic bicyclic compounds as usp1 inhibitors and the use thereof
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003073989A2 (en) 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
MY137843A (en) 2002-09-04 2009-03-31 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
CA2497444C (en) 2002-09-04 2010-11-30 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US20070179161A1 (en) 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
US20050130974A1 (en) 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
WO2006002284A1 (en) 2004-06-22 2006-01-05 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
RS52458B (sr) 2005-02-04 2013-02-28 Millennium Pharmaceuticals Inc. Inhibitori e1 aktivirajućih enzima
TWI333953B (en) 2005-10-06 2010-12-01 Schering Corp Pyrazolopyrimidines as protein kinase inhibitors
EA024006B1 (ru) 2006-02-02 2016-08-31 Миллениум Фармасьютикалз, Инк. Ингибиторы е1 активирующих ферментов
EP1992008A1 (en) * 2006-02-28 2008-11-19 Sez Ag Device and method for liquid treating disc-like articles
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
ZA200900670B (en) * 2006-08-08 2010-04-28 Millennium Pharm Inc Heteroaryl compounds useful as inhititors of E1 activating enzymes
JP5539864B2 (ja) 2007-06-12 2014-07-02 アカオゲン,インコーポレーテッド 抗菌剤
EP2178880B1 (en) 2007-08-02 2017-10-04 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
EP2430026A1 (en) 2009-05-14 2012-03-21 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
MX2012010115A (es) 2010-03-01 2013-02-26 Gtx Inc Compuestos para el tratamiento de cancer.
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
JP6038150B2 (ja) 2011-08-24 2016-12-07 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Nedd8活性化酵素阻害剤
EP2814791A4 (en) 2012-02-17 2015-08-19 Millennium Pharm Inc PYRAZOLOPYRIMIDINYL INHIBITORS OF ACTIVATION ENZYME OF UBIQUITIN
EP2879681A4 (en) 2012-08-03 2015-12-23 Millennium Pharm Inc INDOINDUBSTITUTED PYRROLOPYRIMIDINYL HIBITORS OF UBA6
JP6378759B2 (ja) 2013-07-02 2018-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Sumo活性化酵素阻害剤として有用なヘテロアリール化合物
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme

Also Published As

Publication number Publication date
MX352963B (es) 2017-12-15
CO7071135A2 (es) 2014-09-30
DOP2014000187A (es) 2014-10-15
EP3173413A1 (en) 2017-05-31
CN104136399B (zh) 2018-08-07
JP6122877B2 (ja) 2017-04-26
EP2814791A4 (en) 2015-08-19
CL2014002181A1 (es) 2014-12-12
EP3536692A1 (en) 2019-09-11
NZ628969A (en) 2017-03-31
US9290500B2 (en) 2016-03-22
EA035020B1 (ru) 2020-04-17
AR092797A1 (es) 2015-05-06
MX2014009944A (es) 2014-11-10
SG10201606581RA (en) 2016-09-29
BR112014020365A2 (pt) 2020-12-22
TWI593688B (zh) 2017-08-01
BR112014020365B1 (pt) 2023-02-23
HK1201817A1 (en) 2015-09-11
PH12014501832A1 (en) 2014-11-17
JP2015508775A (ja) 2015-03-23
US20170217968A1 (en) 2017-08-03
EA201400831A1 (ru) 2014-12-30
ZA201406103B (en) 2017-11-29
WO2013123169A1 (en) 2013-08-22
US20130217682A1 (en) 2013-08-22
EP3536692B1 (en) 2021-04-07
GEP201706687B (en) 2017-06-26
PE20142244A1 (es) 2015-01-07
US20160244455A1 (en) 2016-08-25
EP3173413B1 (en) 2019-05-01
TW201345909A (zh) 2013-11-16
CR20140380A (es) 2014-10-28
EP2814791A1 (en) 2014-12-24
CN104136399A (zh) 2014-11-05
SG11201404757WA (en) 2014-09-26
CA2864672A1 (en) 2013-08-22
US9796725B2 (en) 2017-10-24
TN2014000351A1 (en) 2015-12-21
IL234016A0 (en) 2014-09-30
US9663525B2 (en) 2017-05-30
MA35932B1 (fr) 2014-12-01
CA2864672C (en) 2018-01-09
KR20140123104A (ko) 2014-10-21
UA116534C2 (uk) 2018-04-10
US20140088096A9 (en) 2014-03-27
UY34629A (es) 2013-09-02
US20170369499A1 (en) 2017-12-28
US10202389B2 (en) 2019-02-12
ES2739150T3 (es) 2020-01-29

Similar Documents

Publication Publication Date Title
ECSP14019113A (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina
CY1124068T1 (el) Στερεες μορφες ενος εκλεκτικου αναστολεα cdk4/6
UY39630A (es) Inhibidores de bromodominios
PH12017502141A1 (en) Compounds and their methods of use
UA111382C2 (uk) Інгібітори протеїнкінази
MX2012012527A (es) Compuestos quimicos.
DOP2014000062A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
UY35243A (es) Inhibidores de fosfatidilinositol 3-cinasa
CR20190156A (es) Derivados de bipirazol como inhibidores jak
EA201391626A1 (ru) Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
CL2014000746A1 (es) Compuestos derivados de 3-pirimidin-4-il-oxazolidin-2-ona y sus sales, como inhibidores de las proteinas idh mutantes; composicion farmaceutica que los comprende, utiles para el tratamiento de trastornos de la proliferacion celular tal como el cancer.
EA201692506A3 (ru) Ингибиторы репликации вирусов гриппа
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
TR201816379T4 (tr) DNA-PK inhibitörleri.
MX2013006475A (es) Inhibidores macrociclicos de virus flaviviridae.
ECSP12012103A (es) Inhibidores de virus flaviviridae.
JO3073B1 (ar) مثبطات ثنائية ملتحمة ثلاثية الحلقة ل cdk 4/6 و flt3
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
MX373786B (es) Derivados de pirimidin-2,4-diamina para el tratamiento de cáncer.
ECSP12012104A (es) Inhibidores de virus flaviviridae
MX374452B (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
ECSP11011258A (es) Pirimidinas fusionadas
JO3148B1 (ar) مركب مثبط لإشارات مسار notch
CU24263B1 (es) Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer